## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

|INCOME AND||||||
|---|---|---|---|---|---|
|ENDOWMENTS<br>FROM|Notes|Restricted|Unrestricted|Total Funds|Total Funds|
|||I'unds|Iunds|2020|2019|
|Donations<br>and Legacies||||||
|Membership<br>5ubscd ptions<br>Donations|||51,357<br>-0-|51,357<br>-0-|55,592<br>-0-|
|Legacy from Professor Hannah|Steinberg||60,000|60,000|-0-|
|Other trading activities||||||
|Journal ofPsychopharmacology|||103,686|103,686|10L975|
|BookSales/Royalties|||3,979|3,979|5,508|
|Investment<br>Income||||||
|Bank interest|||686|686|659|
|Dividends|||-0-|-0-|-0-|
|Charitable<br>activities||||||
|Ivleeting income|||179,526|179,526|458,906|
|Certificate income|||450|4SO|-0-|
|Online<br>CPD Resource|||61,800|61,800|49,667|
|Other income||||||
|Otherincome|||2,584|2,584|500|
|Total incoming resources||E -0-|6464,068|6464,068|6672,807|





## 

## 

|EXPENDITURE ON|Notes|Restricted|Unrestricted|Total Funds|Total Funds|
|---|---|---|---|---|---|
|||Funds|Funds|2020|2019|
|Raising Donations<br>and Legacies||||||
|Journal ofPsychopharmacology|||-0-|-0-|2,780|
|Promotion<br>Costs|||1,250|1,250|5,566|
|BookCosts|||70|70|6,078|
|Charitable<br>activities||||||
|Meeting expenses|2||97,948|97,948|381,086|
|BAP Initiatives|3||13,724|13,724|20,572|
|Prizes<br>Affiliation|||2,450|2,450|4,120|
|Research Internships|||13,500|13,500|-0-|
|Certificate expenses|4|||-0-|31|
|t Other Societies|||2,185|2,185|2,276|
|Secretarial and other staff costs|6||139,904|139,904|139,689|
|Computer system/software/server||||||
|support|||20,029|20,029|15,795|
|Printing,<br>postage and stationery|||4,978|4,978|8,584|
|Support Costs||||||
|Office insurance|||1,808|1,808|1,808|
|Repairs and maintenance|||274|274|1,347|
|Council tax and water|||3,132|3.132|3,191|
|Light and heat|||1,700|1,700|1,419|
|Cleaning|||880|880|960|
|Telephone<br>costs|||3,217|3,217|3,531|
|Bank and card processing charges|||5,212|5,212|8,711|
|Sundry expenses|||555|555|111|
|Depreciation|||13,543|13,543|14,270|
|Council meetings expenses|||3,034|3,034|8,135|
|Accountancy|||2,546|2,546|2,472|
|Payroll service costs|||693|693|2,378|
|Total resources expended|||332,582|332,582|634,910|
|Net Gains/(Losses)<br>on investments||-0-|162,339|162,339|211,727|
|NET (EXPENDITURE)/ INCOME||6-0-|E293,825|F293,825|f249,624|





## 

## 

## 

||||Notes|Restricted|Unrestricted|Total|
|---|---|---|---|---|---|---|
|||||Funds|Funds|2020|
|Net (Expenditure) /|Inrorne|I'or Ihe Year||0|293,825|1/,800|
|Total Funds brought|forward|||E6,069|2,125,646|2,131,715|
|Total Funds carried|forward|||E6,069|E2,419,471|E2,159,515|





## 

## 

|||Notes|Unrestricted|Restricted|Total Funds|Total Funds|
|---|---|---|---|---|---|---|
||||iunds|Funds|2020|2019|
|Fixed Assets|||||||
|Tangible assets<br>investments||7<br>8|256,459<br>1,7ss,coo|-0-<br>-0-|256,459<br>z,755,900|270,002<br>1,593,561|
||||2,012,359||2,012,359|1,863,563|
|Current Assets|||||||
|Debtors||9|117,552|-0-|117,552|104,918|
|Cash at bank|||365,377|6,069|371,446|273,642|
||||482,929|6,069|488,998|378,560|
|Creditors|||||||
|Amounts<br>falling due within one year||10|(75,817)|-0-|(75,817)|(110,410)|
|Net Current|Assets||407,112|6,069|413,181|268,150|
|Total Assets|Less Current Uabilities||2,315,785|6,069|2,321,854|2,131,713|
|Net Assets|||f2,419,471|f6,069|f2,425,540|f2,131,713|
|FUNDS|||||||
|Unrestricted|Funds||||2,419,471|2,12S,644|
|Restricted<br>Funds|||||6,069|6,069|
||||||f2,425,540|62,131,713|





## 




## 

## 

|forthe<br>ear ended 31"Decemb|||||
|---|---|---|---|---|
|||Notes|2020|2019|
|Cash flows from operating<br>activities:|||||
|Cash generated<br>from operations|||97,118|68,274|
|Net cash provided<br>by (used in)|||||
|opomtron<br>activities|||97,118|68,274|
|Cash flows from investing<br>activities:<br>Purchase oftangible fixed assets<br>Purchase offixed assets investments|||-0-<br>-0-|-0-<br>-0-|
|Interest received|||686|659|
|Net cash provided<br>by (used in)|||||
|investing<br>activities|||686|659|
|Change<br>in cash and cash equivalents|in||||
|reporting<br>period|||97,804|68,933|
|Cash and cash equivalents<br>at the beginning|||||
|ofthe reporting<br>period|||273,642|204,709|
|Cash and cash equivalents<br>atthe end|ofthe||||
|reporting<br>period|||f371,446|f273,642|





## 

## 

## 

||||2020|2019|
|---|---|---|---|---|
|Net (expenditure)/<br>income for the reporting||period (as per the|||
|statement offinancia activities)|||293,825|249,624|
|Adjustments<br>for:|||||
|Depreciation<br>charges|||13,543|14,270|
|Losses/(Gain)<br>on Investments|||(162,339)|(211,727)|
|Interest received|||(686)|(659)|
|(Increase) / Decrease in debtors|||(12,634)|10,509|
|(Decrease) / Increase in creditors|||(34,591)|6,257|
|Net cash provided<br>by (used in) operating|activities||E97,118|E68,274|





## 

## 

## 

## 

## 

## 

## 



## 



## 

## 

## 

||||||Surplus|
|---|---|---|---|---|---|
||||Income|Expenses|(Deficit)|
|January 2020|Bristol-|||||
||Anxiety disorders||25,070|17,797|7,273|
|March 2020|Cambridge-|||||
||Non-Clinical|Certificate|10,430|11,943|(1,513)|
|November 2020|Online-|||||
||Child and Adolescent||26,704|13,150|13,554|
|Cancelled|Online-|||||
||Masterclasses||25,963|18,993|6,970|
|Cancelled|Cancelled-|||||
||Schizophrenia||404|3,764|(3,360)|
|Cancelled|Cancelled-|||||
||Summer Meeting||675|1,013|(338)|
|September 2020|Online-|||||
||Affective Disorders||15,231|5,425|9,806|
|Cancelled|Cancelled-|||||
||Old Age||1,567|1,039|528|
|October 2020|Online-|||||
||Child and Adolescent||14,940|6,348|8,592|
|November 2020|Online-|||||
||Masterclasses||41,920|12,772|29,148|
|December 2020|Online-|||||
||Substance<br>Misuse||16,622|5,704|10,918|
||||6179,526|697,948|681,578|





## 

## 

|BAP initiatives|||2020|2019|
|---|---|---|---|---|
|In Vivo Training|Fund|||5,000|
|Online CPD Resource|||10,724|5,522|
|Robert Kerwin|Bursaries||||
|VPM Library|||-0|4,050|
|Newcastle<br>University||Stipend covering 2020|3,000|-6,000|
||||13,724|E20,572|



## 

## 

## 



## 

|4.|Certificate Income and Expenses|2020|2019|
|---|---|---|---|
||Clinical Certiffcate|||
||Income|450|-0-|
||Less:<br>Expenses|-0-|31|
|||E450|E(31)|
||Restricted Funds|||
||Balance at01.01.20<br>Incoming Resources||6,069<br>-0-|
||Expenditure||-0-|
||Balance at 31.12.20||E6,069|



|6.|Staff Costs||||||
|---|---|---|---|---|---|---|
||The staff costs were:||||||
||||||2020|2019|
||Salaries||||125,901|126,541|
||Pension Costs||||14,003|13,148|
||||||E139,904|E139,689|
||The average monthly||number ofemployees||dudng the year was asfollows:||
||||||2020|2019|
||Administrative||||||
||No employee|received emoluments||in excess ofE60,000.|||





## 

|7.|Fixed Assets|||||||
|---|---|---|---|---|---|---|---|
||||||Fixtures|||
||||Property|Equipment|Ik|Fittings|Totals|
||Cost|||||||
||Asat01.01.20<br>Additions||-0-|3%,651<br>-0-||8,284<br>-0-|567,894<br>-0-|
||As at31.12.20||525,959|33,651||8,284|567,894|
||Depreciation|||||||
||As at01.01.20||256,170|33,468||8,254|297,892|
||Charge for the Year||13,489|46||8|13,543|
||As at31.12.20||269,659|33,514||8,262|311,435|
||Net BookValue|||||||
||As at31.12.20||6256,300|137|E|22|6256,459|
||As at31.12.19||E269,789|183|E|30|f270,002|
|8,|Fixed Asset Investments|||||||
||||||||Market|
||||||||Value as|
||Units||||Cost||at31.12.20|
|||MIXED ASSET FUNDS||||||
||1,057,580<br>-0-|As at01.01.20<br>Additions|||1,138,200<br>-0-|||
||E1,057,580|As at31.12.20|||E1,138,200||E1,755,900|





## 

## 

|9,|Debtors||||||
|---|---|---|---|---|---|---|
||||||2020|2019|
||Outstanding|journal||income|103,686|101,975|
||Outstanding|meeting||Income|491|984|
||Meeting expenses||paid in advance||13,375|1,959|
||||||f117,552|f104,918|
|10.|Creditors and Accruals||||||
||||||2020|2019|
||Outstanding|meeting||expenses|7,239|4,105|
||Accrued meeting||income||66,032|103,833|
||Other creditors||||2,546|2,472|
||||||f75,817|f110,410|



